Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.14 USD | +2.25% | +3.77% | -35.16% |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 525M | Capitalization | 1.12B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -29M | EV / Sales 2024 * | 2.29 x |
Net cash position 2024 * | 63.34M | Net cash position 2025 * | 76.49M | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
-29.8
x | P/E ratio 2025 * |
-37.1
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on AtriCure, Inc.
1 day | +2.25% | ||
1 week | +3.77% | ||
Current month | -4.06% | ||
1 month | -1.07% | ||
3 months | -29.28% | ||
6 months | -44.24% | ||
Current year | -35.16% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 430 M€ | -.--% | ||
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 23.14 | +2.25% | 533,655 |
24-05-16 | 22.63 | +2.31% | 536,197 |
24-05-15 | 22.12 | +1.05% | 500,481 |
24-05-14 | 21.89 | -2.58% | 622,762 |
24-05-13 | 22.47 | +0.76% | 944,898 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.16% | 1.12B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- ATRC Stock